vs
Side-by-side financial comparison of SunOpta Inc. (STKL) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $205.4M, roughly 1.4× SunOpta Inc.). Bio-Techne runs the higher net margin — 12.8% vs 0.4%, a 12.4% gap on every dollar of revenue. On growth, SunOpta Inc. posted the faster year-over-year revenue change (16.6% vs -6.4%). Over the past eight quarters, SunOpta Inc.'s revenue compounded faster (7.4% CAGR vs 4.2%).
SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
STKL vs TECH — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $295.9M |
| Net Profit | $816.0K | $38.0M |
| Gross Margin | 12.4% | 64.6% |
| Operating Margin | 3.3% | 18.4% |
| Net Margin | 0.4% | 12.8% |
| Revenue YoY | 16.6% | -6.4% |
| Net Profit YoY | 113.1% | 68.3% |
| EPS (diluted) | $0.01 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.9M | ||
| Q3 25 | $205.4M | — | ||
| Q2 25 | $191.5M | $317.0M | ||
| Q1 25 | $201.6M | $316.2M | ||
| Q4 24 | $193.9M | $297.0M | ||
| Q3 24 | $175.9M | $289.5M | ||
| Q2 24 | $169.5M | $306.1M | ||
| Q1 24 | $184.4M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $816.0K | — | ||
| Q2 25 | $4.4M | $-17.7M | ||
| Q1 25 | $4.8M | $22.6M | ||
| Q4 24 | $-8.7M | $34.9M | ||
| Q3 24 | $-6.2M | $33.6M | ||
| Q2 24 | $-5.3M | $40.6M | ||
| Q1 24 | $2.9M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | 12.4% | — | ||
| Q2 25 | 14.8% | 62.7% | ||
| Q1 25 | 15.0% | 67.9% | ||
| Q4 24 | 10.9% | 65.3% | ||
| Q3 24 | 13.0% | 63.2% | ||
| Q2 24 | 12.5% | 66.4% | ||
| Q1 24 | 16.8% | 67.4% |
| Q4 25 | — | 18.4% | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 5.5% | -7.5% | ||
| Q1 25 | 5.2% | 12.2% | ||
| Q4 24 | 1.4% | 16.0% | ||
| Q3 24 | 0.5% | 13.8% | ||
| Q2 24 | 1.2% | 15.0% | ||
| Q1 24 | 5.5% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 2.3% | -5.6% | ||
| Q1 25 | 2.4% | 7.1% | ||
| Q4 24 | -4.5% | 11.7% | ||
| Q3 24 | -3.5% | 11.6% | ||
| Q2 24 | -3.1% | 13.3% | ||
| Q1 24 | 1.6% | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.03 | $-0.11 | ||
| Q1 25 | $0.04 | $0.14 | ||
| Q4 24 | $-0.08 | $0.22 | ||
| Q3 24 | $-0.05 | $0.21 | ||
| Q2 24 | $-0.04 | $0.26 | ||
| Q1 24 | $0.02 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $172.9M |
| Total DebtLower is stronger | $250.8M | $260.0M |
| Stockholders' EquityBook value | $162.8M | $2.0B |
| Total Assets | $694.1M | $2.5B |
| Debt / EquityLower = less leverage | 1.54× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $2.2M | $162.2M | ||
| Q1 25 | $2.3M | $140.7M | ||
| Q4 24 | $1.6M | $177.5M | ||
| Q3 24 | $2.9M | $187.5M | ||
| Q2 24 | $3.2M | $152.9M | ||
| Q1 24 | $1.5M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | $250.8M | — | ||
| Q2 25 | $263.3M | $346.0M | ||
| Q1 25 | $260.6M | $330.0M | ||
| Q4 24 | $265.2M | $300.0M | ||
| Q3 24 | $289.9M | $300.0M | ||
| Q2 24 | $303.1M | $319.0M | ||
| Q1 24 | $258.8M | $389.0M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $162.8M | — | ||
| Q2 25 | $159.8M | $1.9B | ||
| Q1 25 | $154.8M | $2.0B | ||
| Q4 24 | $148.6M | $2.1B | ||
| Q3 24 | $155.0M | $2.1B | ||
| Q2 24 | $158.8M | $2.1B | ||
| Q1 24 | $163.6M | $2.0B |
| Q4 25 | — | $2.5B | ||
| Q3 25 | $694.1M | — | ||
| Q2 25 | $704.9M | $2.6B | ||
| Q1 25 | $690.7M | $2.6B | ||
| Q4 24 | $668.5M | $2.7B | ||
| Q3 24 | $699.3M | $2.7B | ||
| Q2 24 | $704.7M | $2.7B | ||
| Q1 24 | $671.8M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | 1.54× | — | ||
| Q2 25 | 1.65× | 0.18× | ||
| Q1 25 | 1.68× | 0.16× | ||
| Q4 24 | 1.78× | 0.14× | ||
| Q3 24 | 1.87× | 0.14× | ||
| Q2 24 | 1.91× | 0.15× | ||
| Q1 24 | 1.58× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $12.1M | — |
| FCF MarginFCF / Revenue | 5.9% | — |
| Capex IntensityCapex / Revenue | 2.1% | — |
| Cash ConversionOCF / Net Profit | 20.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | $36.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $16.3M | — | ||
| Q2 25 | $-4.5M | $98.2M | ||
| Q1 25 | $22.3M | $41.1M | ||
| Q4 24 | $33.1M | $84.3M | ||
| Q3 24 | $17.2M | $63.9M | ||
| Q2 24 | $-5.6M | $75.5M | ||
| Q1 24 | $5.3M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | $12.1M | — | ||
| Q2 25 | $-9.2M | $93.3M | ||
| Q1 25 | $9.5M | $31.0M | ||
| Q4 24 | $24.0M | $77.5M | ||
| Q3 24 | $11.7M | $54.7M | ||
| Q2 24 | $-15.3M | $57.5M | ||
| Q1 24 | $-2.3M | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | -4.8% | 29.4% | ||
| Q1 25 | 4.7% | 9.8% | ||
| Q4 24 | 12.4% | 26.1% | ||
| Q3 24 | 6.6% | 18.9% | ||
| Q2 24 | -9.0% | 18.8% | ||
| Q1 24 | -1.2% | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 2.5% | 1.5% | ||
| Q1 25 | 6.3% | 3.2% | ||
| Q4 24 | 4.7% | 2.3% | ||
| Q3 24 | 3.2% | 3.2% | ||
| Q2 24 | 5.7% | 5.9% | ||
| Q1 24 | 4.1% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | 20.03× | — | ||
| Q2 25 | -1.03× | — | ||
| Q1 25 | 4.63× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | 1.83× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
STKL
| Beverages And Broths | $161.4M | 79% |
| Fruit Snacks | $40.9M | 20% |
| Ingredients | $3.1M | 2% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
